Artwork for podcast Eczema Breakthroughs
The surprising relationship between COVID risk & eczema
Episode 167th January 2022 • Eczema Breakthroughs • Global Parents for Eczema Research (GPER)
00:00:00 00:27:05

Share Episode


At the beginning of the pandemic, the prevailing theory was that people with eczema would be at higher risk for COVID-19 infection and impacts because so many are using steroid treatments and also suffer from asthma, which many guessed would make respiratory infections worse. But, in a rare bit of good news, the exact opposite may be true! Tune in to learn how the immune system abnormalities associated with eczema may actually protect against COVID-19 infection and how one treatment may reduce the risk of severe symptoms after infection. Our guests are Dr. Emma Guttman-Yassky, Professor of Dermatology and Immunology at the Icahn School of Medicine at Mount Sinai; Dr. Benjamin Ungar Assistant Professor of Dermatology also at Mount Sinai; and Dr. Adrian Martineau Professor of Respiratory Infection and Immunity Sciences in the School of Medicine at Queen Mary University of London.

Research referenced in this episode:

COVID-19 Symptoms in Patients Treated with Dupilumab

Risk factors for developing COVID-19